Chronic StrokeNCT05376982
Comparison of NT Vs Body Weight Supported TT Along With CT on Lower Extremity in Chronic Stroke Patients
A study testing Neurodevelopmental Treatment and Body weight supported treadmill training along with conventional therapy in people with Chronic Stroke, run by Superior University at 1 site in Pakistan.
Trial summary
To determine the effect of Neurodevelopment Treatment vs Body Weight Supported Treadmill Training along with conventional therapy on lower extremity among chronic stroke patients. Read more about this study
- Who is it for?
- Ages 35 years and older
- Conditions the study is for
- Chronic Stroke
- What is being tested?
- Neurodevelopmental Treatment and Body weight supported treadmill training along with conventional therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 1 sitePakistan
- Study dates
- 31 Mar 2022to 1 Aug 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Application of M-Cog test for checking patients cognition.
- Chronic ischemic stroke patients.
- Both Male and Female Patients.
- Patients of 35 or above years of age.
Who cannot join
- Patients with history of recurrent stroke.
- Patients with lower limb fractures or dislocations.
- Patients with Peripheral vascular disease
- Patients with skin discoloration or skin ulcers.
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
• General Hospital. • Chaudhary Muhammad Akram Teaching and Research Hospital, University of Lahore Teaching Hospital, Shadman Medical Center, Services Hospital, Bahria International Hospital
Lahore
About this study
Official title: Comparison of Neurodevelopmental Treatment Vs Body Weight Supported Treadmill Training Along With Conventional Therapy on Lower Extremity Among Chronic Stroke Patients
To determine the effect of Neurodevelopment Treatment vs Body Weight Supported Treadmill Training along with conventional therapy on lower extremity among chronic stroke patients.
- Conditions
- Chronic Stroke
- Being tested
- Neurodevelopmental Treatment, Body weight supported treadmill training along with conventional therapy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Neurodevelopmental TreatmentDiagnostic test
Using Neurodevelopmental Treatment Method
Body weight supported treadmill training along with conventional therapyDiagnostic test
Using Body weight supported treadmill training along with conventional therapy Method
| Study group | Role | What they receive |
|---|---|---|
| Neurodevelopmental Treatment | Experimental | Using Neurodevelopmental Treatment Method Receives: Diagnostic Test: Neurodevelopmental Treatment |
| Body weight supported treadmill training along with conventional therapy | Experimental | Using Body weight supported treadmill training along with conventional therapy Method Receives: Diagnostic Test: Body weight supported treadmill training along with conventional therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
For lower extremity among chronic stroke patients
comparison of neurodevelopmental treatment vs body weight supported treadmill training along with conventional therapy on lower extremity among chronic stroke patients
Measured: 6 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 May 2022
- Study start31 Mar 2022
- Primary completion13 Jul 2022
- Study completion1 Aug 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic StrokeStudies of the same condition, open and under way.
- More trials run by Superior UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- Superior University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Muhammad Naveed Babur, Superior University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05376982
- Sponsor's protocol ID
- DPT/Batch-Fall17/506
- Status last verified
- Aug 2022
- First submitted
- 5 May 2022
- Last updated
- 4 Aug 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Neurodevelopmental Treatment Vs Body Weight Supported Treadmill Training Along With Conventional Therapy on Lower Extremity Among Chronic Stroke Patients
- ClinicalTrials.gov ID
- NCT05376982
- Acronym / sponsor ID
- DPT/Batch-Fall17/506
- Conditions
- Chronic Stroke
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 42 participants (actual)
- Lead sponsor
- Superior UniversityUniversity, hospital or other
- Study start
- 31 Mar 2022 (actual)
- Primary completion
- 13 Jul 2022 (actual)
- Study completion
- 1 Aug 2022 (actual)
- First posted
- 17 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To determine the effect of Neurodevelopment Treatment vs Body Weight Supported Treadmill Training along with conventional therapy on lower extremity among chronic stroke patients.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Neurodevelopmental Treatment | Experimental | Diagnostic Test: Neurodevelopmental TreatmentUsing Neurodevelopmental Treatment Method |
| Body weight supported treadmill training along with conventional therapy | Experimental | Diagnostic Test: Body weight supported treadmill training along with conventional therapyUsing Body weight supported treadmill training along with conventional therapy Method |
Who may qualify
- Ages
- 35 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Application of M-Cog test for checking patients cognition.
- Chronic ischemic stroke patients.
- Both Male and Female Patients.
- Patients of 35 or above years of age.
Key exclusion criteria (4 listed)
- Patients with history of recurrent stroke.
- Patients with lower limb fractures or dislocations.
- Patients with Peripheral vascular disease
- Patients with skin discoloration or skin ulcers.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Neurodevelopmental TreatmentUsing Neurodevelopmental Treatment Method | Diagnostic test | Neurodevelopmental Treatment |
| Body weight supported treadmill training along with conventional therapyUsing Body weight supported treadmill training along with conventional therapy Method | Diagnostic test | Body weight supported treadmill training along with conventional therapy |
Primary outcome
For lower extremity among chronic stroke patients
Time frame: 6 Months
comparison of neurodevelopmental treatment vs body weight supported treadmill training along with conventional therapy on lower extremity among chronic stroke patients
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Aug 2022.
- Individual participant dataSharing planned: No
Related trials for Chronic Stroke
Recruiting
Effect of Anomia Rehabilitation Combined With Metacognitive Training in Patients With Chronic Vascular Aphasia
Aphasia, Stroke
Recruiting
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
Stroke, Ischemic, Chronic Stroke
RecruitingPhase 3
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease
Not yet recruiting
Proof-of-concept for Use of Transcutaneous Spinal Stimulation (TSS) With the ExaStim® Stimulation System in Adults With Chronic Ischemic Stroke
Chronic Stroke, Ischemic Stroke
Recruiting
Task-Oriented Training Versus High-Intensity Gait Training in People With Chronic Stroke
Stroke, Hemiplegia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Neurodevelopmental Treatment and Body weight supported treadmill training along with conventional therapy in people with Chronic Stroke, run by Superior University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
For lower extremity among chronic stroke patients (time frame: 6 Months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2022.